De Nederlandse overheid heeft besloten om 81 M Euro te reserveren voor Nederlandse kennis en innovatie in de life sciences en health sector. lees meer >>

110 miljoen euro voor moleculair onderzoek naar hart- en vaatziekten lees meer >>

In een special over het BCF event (carrièrebeurs op 28 mei), publiceerde ‘De Pers’ een artikel over het CTMM, de formule voor het publiek-private partnerschap en de vele vacatures voor promovendi en postdocs. lees meer >>

Het CTMM (Center for Translational Molecular Medicine) – het Nederlandse publiek-private samenwerkingsverband dat zich richt op het onderzoeken en ontwikkelen van nieuwe technieken voor de diagnose en behandeling van de belangrijkste chronische aandoeningen –heeft vandaag aangekondigd dat het 100 miljoen euro beschikbaar heeft gesteld voor acht nieuwe onderzoeksprojecten. lees meer >>

Output boekjes

In het Engels:

If you want to see what 300 million euros of public-private partnership funding can achieve, take a look at the new set of output booklets that have been prepared for the individual CTMM projects.

Scientific breakthroughs, new products, patents, start-up companies, research infrastructures, PhD theses and academic papers, it's all there in black and white - proof that together we have achieved something truly remarkable and placed the Netherlands in a world leading position for translational medical research.

AIRFORCE - personalized chemotherapy against lung cancer

BIOCHIP - Diagnosing leukemia sub-types

Breast CARE - Predicting therapy response in breast cancer patients

DeCoDe - Early diagnosis of colorectal cancer

HIFU-CHEM - More chemo where it should be

MUSIS - Check removal of tumor tissue during surgery

PCMM - Limit over-diagnosis and over-treatment in prostate cancer

VOLTA - Remove tumors through local heating

Circulating Cells - investigating white blood cells and platelets for discriminating patients with increased risk of developing unstable plaques

COHFAR - how to detect and stop ventricular fibrillation by applying a synchronized electrical impulse to heart muscle

Eminence - developing multiple diagnostic technologies to detect neovascularization and stratifying patients

INCOAG - developing a new set of tests to estimate the risk of thrombosis

Parisk - how to predict risk of rupture of an individual plaque

Predicct - focusing on early diagnoses and treatment of Diabetes DM2

Triumph - identifying biomarkers for cardiac failure

LeARN - finding an early diagnosis of Alzheimer's Disease

AmpVacs - a new vaccine technology platform in the combat against conserved influenza A determinants

MARS - tools to provide rapid and accurate information about an individual patient suffering from sepsis

TRACER - patient-tailored treatment of Rheumatoid Arthritis

Health Technology Assessment (HTA)

TraIT - establishing an easy-to-access and easy-to-use infrastructure for sharing of research data, and set of tools for researchers to interact with and explore a unified translational medical research space

March 2018